Business Standard

Monday, December 23, 2024 | 09:22 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Aarti Drugs extends rally on share buyback proposal; hits 52-week high

The pharmaceutical company's stock has rallied 20 per cent in the past four trading days, as compared to 2 per cent rise in the S&P BSE Sensex

Buybacks
Premium

Buybacks

SI Reporter Mumbai
Shares of Aarti Drugs hit a 52-week high of Rs 705, up 5 per cent, on the BSE in intra-day trade on Monday after the company said its board will meet on Friday, March 15 to consider a share buyback proposal.

“The meeting of the board of directors of the company is scheduled to be held on Friday, 15th March, 2019, to consider proposal of buyback of the fully paid-up equity shares of the company including matters related/incidental thereto,” Aarti Drugs said in a regulatory filing.

The pharmaceutical company's stock has rallied 20 per cent in the past four trading

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in